These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38613946)

  • 1. Hypothalamic-pituitary-adrenal axis hyperactivity is normalized after successful intermittent theta-burst stimulation in resistant depressed patients.
    Duval F; Mokrani MC; Danila V; Weiss T; Lopera FG; Tomsa M
    Psychoneuroendocrinology; 2024 Jul; 165():107037. PubMed ID: 38613946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Duprat R; Desmyter S; Rudi de R; van Heeringen K; Van den Abbeele D; Tandt H; Bakic J; Pourtois G; Dedoncker J; Vervaet M; Van Autreve S; Lemmens GM; Baeken C
    J Affect Disord; 2016 Aug; 200():6-14. PubMed ID: 27107779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
    Blumberger DM; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Downar J
    Lancet; 2018 Apr; 391(10131):1683-1692. PubMed ID: 29726344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C; Baghai T; Zwanzger P; Minov C; Padberg F; Rupprecht R
    J Psychiatr Res; 2001; 35(4):239-47. PubMed ID: 11578642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
    Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the thyroid and adrenal system alterations linked in depression?
    Mokrani MC; Duval F; Erb A; Gonzalez Lopera F; Danila V
    Psychoneuroendocrinology; 2020 Dec; 122():104831. PubMed ID: 33068950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of one HF-rTMS session on mood and salivary cortisol in treatment resistant unipolar melancholic depressed patients.
    Baeken C; De Raedt R; Leyman L; Schiettecatte J; Kaufman L; Poppe K; Vanderhasselt MA; Anckaert E; Bossuyt A
    J Affect Disord; 2009 Feb; 113(1-2):100-8. PubMed ID: 18571733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline 'state anxiety' influences HPA-axis sensitivity to one sham-controlled HF-rTMS session applied to the right dorsolateral prefrontal cortex.
    Baeken C; Vanderhasselt MA; De Raedt R
    Psychoneuroendocrinology; 2011 Jan; 36(1):60-7. PubMed ID: 20599325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis.
    Lopez-Duran NL; Kovacs M; George CJ
    Psychoneuroendocrinology; 2009 Oct; 34(9):1272-83. PubMed ID: 19406581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis hyperactivity is associated with decreased brain-derived neurotrophic factor in female suicide attempters.
    Ambrus L; Lindqvist D; Träskman-Bendz L; Westrin Å
    Nord J Psychiatry; 2016 Nov; 70(8):575-81. PubMed ID: 27216156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of intermittent theta burst stimulation compared to conventional repetitive transcranial magnetic stimulation in patients with treatment resistant depression: A cost analysis.
    Mendlowitz AB; Shanbour A; Downar J; Vila-Rodriguez F; Daskalakis ZJ; Isaranuwatchai W; Blumberger DM
    PLoS One; 2019; 14(9):e0222546. PubMed ID: 31513675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):88-92. PubMed ID: 19054568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In search of the HPA axis activity in unipolar depression patients with childhood trauma: Combined cortisol awakening response and dexamethasone suppression test.
    Lu S; Gao W; Huang M; Li L; Xu Y
    J Psychiatr Res; 2016 Jul; 78():24-30. PubMed ID: 27049575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trait-dependent effects of theta burst stimulation after psychosocial stress: a sham-controlled study in healthy individuals.
    De Smet S; Int-Veen I; Vanhollebeke G; Pulopulos MM; Barth B; Pasche S; Baeken C; Nuerk HC; Plewnia C; Nieratschker V; Jochen Fallgatter A; Ehlis AC; Vanderhasselt MA; Rosenbaum D
    Clin Neurophysiol; 2024 Jun; 162():235-247. PubMed ID: 38556367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute administration of buspirone increases the escape of hypothalamic-pituitary-adrenal-axis hormones from suppression by dexamethasone in depression.
    Maes M; Van Gastel A; Meltzer HY; Cosyns P; Blockx P; Desnyder R
    Psychoneuroendocrinology; 1996 Jan; 21(1):67-81. PubMed ID: 8778905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prefrontal theta-burst stimulation on brain function in treatment-resistant depression: A randomized sham-controlled neuroimaging study.
    Li CT; Chen MH; Juan CH; Liu RS; Lin WC; Bai YM; Su TP
    Brain Stimul; 2018; 11(5):1054-1062. PubMed ID: 29730251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-inferiority of intermittent theta burst stimulation over the left V
    Kong Y; Zhou J; Zhao M; Zhang Y; Tan T; Xu Z; Hou Z; Yuan Y; Tan L; Song R; Shi Y; Feng H; Wu W; Zhao Y; Zhang Z
    J Affect Disord; 2023 Dec; 343():59-70. PubMed ID: 37751801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive role of impulsivity, anxiety, and depression in the efficacy of intermittent theta burst transcranial magnetic stimulation modalities for treating methamphetamine use disorder: A randomized clinical trial.
    Ren Z; Mu L; Wang L; Xia L; Song P; Wang Y; Li J; Duan F; Li H; Tang H; Wang W; Zhu L; Zhang L; Song X; Wang Y; Zhao W; Zhu Y; Wang Z; Shao W; Zhang X; Jiao D
    J Subst Use Addict Treat; 2024 Jan; 156():209189. PubMed ID: 37866441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.